Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.
An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...
For the roughly 40 million Americans who swallow a statin pill every morning, the routine is simple but relentless: miss ...
(Peopleimages.com/YuriArcurs/Canva) For millions of people, statins are a daily shield against heart disease. But around 10 ...
A one-time gene-editing infusion kept cholesterol levels low for a year, offering a potential new approach to preventing ...
If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...
One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...
Statins are among the most commonly prescribed medications for reducing high cholesterol and lowering the risk of heart attack and stroke. People searching for popular statin medications are often ...
Statins have been blamed for everything short of causing bad hair days—especially by the alternative-medicine crowd, who treat “Lipitor” like it’s a controlled substance. A new Lancet meta-analysis of ...